• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种新型交联聚合物抗结核药物递送系统的配方设计与统计优化

Formulation and statistical optimization of a novel crosslinked polymeric anti-tuberculosis drug delivery system.

作者信息

du Toit Lisa Claire, Pillay Viness, Danckwerts Michael Paul, Penny Clement

机构信息

Department of Pharmacy and Pharmacology, University of the Witwatersrand, 7 York Road, Parktown 2193, South Africa.

出版信息

J Pharm Sci. 2008 Jun;97(6):2176-207. doi: 10.1002/jps.21159.

DOI:10.1002/jps.21159
PMID:17879985
Abstract

The crux of this research was the pragmatic investigation into the formulation of a reconstitutable multiparticulate anti-tuberculosis drug delivery system for facilitated administration for the attainment of segregated gastrointestinal (GI) delivery of rifampicin (RIF) and isoniazid (INH) in order to address issues of unacceptable RIF bioavailability on coadministration with INH. Ionotropically crosslinked polymeric enterospheres for delivery of INH to the small intestine were developed via a response surface methodology for the design and optimization of the formulation and processing variables. A 3(4) Box-Behnken statistical design was constructed. The concentration of zinc sulfate salting-out and crosslinking electrolyte, the crosslinking reaction time, the drying temperature (DT), and the concentration of triethyl citrate plasticizer were varied for determination of their effect on the molar amount of zinc (n(Zn)) incorporated in the crosslinked enterosphere, drug entrapment efficiency (DEE), and mean dissolution time (MDT) at t(2h) in acidic media (0.1 M HCl). Complexometric determination of zinc cations (Zn(2+)) revealed that 23.70-287.89 mol of Zn(2+) per mole of polymer were implicated in crosslink formation. DEE of 27.92% to 99.77% were obtained. Drug release at t(2h) ranged from 1.67% to 73.04%. The salting-out and crosslinking agent significantly affected n(Zn) (p = 0.034) and the DEE (p = 0.000), as did the concentration of plasticizer employed (p = 0.000 and 0.002, respectively). High DTs (>42.5 degrees C) also significantly improved DEE (p = 0.029). ZnSO(4) had a significant effect on the MDT (p = 0.000). A dry dispersible multiparticulate system incorporating the optimally designed INH-loaded enterospheres and RIF was developed. Bivariate regression analysis of UV spectrophotometric absorbance data allowed in vitro resolution of RIF and INH release at simulated gastric pH.

摘要

本研究的关键在于对一种可重构的多颗粒抗结核药物递送系统进行实用性研究,该系统旨在便于给药,以实现利福平(RIF)和异烟肼(INH)在胃肠道(GI)的分离递送,从而解决与INH合用时RIF生物利用度不可接受的问题。通过响应面法开发了用于将INH递送至小肠的离子交联聚合物肠溶球,以设计和优化制剂及工艺变量。构建了3(4) Box-Behnken统计设计。改变硫酸锌盐析和交联电解质的浓度、交联反应时间、干燥温度(DT)以及柠檬酸三乙酯增塑剂的浓度,以确定它们对交联肠溶球中锌(n(Zn))的摩尔量、药物包封率(DEE)以及在酸性介质(0.1 M HCl)中t(2h)时的平均溶解时间(MDT)的影响。锌阳离子(Zn(2+))的络合测定表明,每摩尔聚合物中有23.70 - 287.89摩尔的Zn(2+)参与交联形成。获得了27.92%至99.77%的DEE。t(2h)时的药物释放率为1.67%至73.04%。盐析和交联剂对n(Zn)(p = 0.034)和DEE(p = 0.000)有显著影响,所用增塑剂的浓度也有显著影响(分别为p = 0.000和0.002)。高温干燥(>42.5摄氏度)也显著提高了DEE(p = 0.029)。ZnSO(4)对MDT有显著影响(p = 0.000)。开发了一种包含优化设计的载INH肠溶球和RIF的干分散多颗粒系统。紫外分光光度吸收数据的双变量回归分析允许在模拟胃pH值下体外解析RIF和INH的释放。

相似文献

1
Formulation and statistical optimization of a novel crosslinked polymeric anti-tuberculosis drug delivery system.一种新型交联聚合物抗结核药物递送系统的配方设计与统计优化
J Pharm Sci. 2008 Jun;97(6):2176-207. doi: 10.1002/jps.21159.
2
Alginate microspheres of isoniazid for oral sustained drug delivery.用于口服持续给药的异烟肼海藻酸盐微球。
Int J Pharm. 2007 Apr 4;334(1-2):71-7. doi: 10.1016/j.ijpharm.2006.10.024. Epub 2006 Oct 21.
3
A mesoporous silicon/poly-(DL-lactic-co-glycolic) acid microsphere for long time anti-tuberculosis drug delivery.介孔硅/聚(DL-乳酸-共-乙醇酸)微球用于长时间抗结核药物递送。
Int J Pharm. 2014 Dec 10;476(1-2):116-23. doi: 10.1016/j.ijpharm.2014.09.040. Epub 2014 Sep 28.
4
Rifampicin-loaded 'flower-like' polymeric micelles for enhanced oral bioavailability in an extemporaneous liquid fixed-dose combination with isoniazid.负载利福平的“花状”聚合物胶束,用于与异烟肼制成临时液体固定剂量组合以提高口服生物利用度。
Nanomedicine (Lond). 2014 Aug;9(11):1635-50. doi: 10.2217/nnm.13.154. Epub 2014 Jan 10.
5
Encapsulation of Rifampicin in a solid lipid nanoparticulate system to limit its degradation and interaction with Isoniazid at acidic pH.将利福平包封在固体脂质纳米粒系统中以限制其在酸性 pH 下的降解和与异烟肼的相互作用。
Int J Pharm. 2013 Mar 25;446(1-2):106-11. doi: 10.1016/j.ijpharm.2013.02.012. Epub 2013 Feb 11.
6
Ascorbic acid improves stability and pharmacokinetics of rifampicin in the presence of isoniazid.在异烟肼存在的情况下,抗坏血酸可提高利福平的稳定性和药代动力学。
J Pharm Biomed Anal. 2014 Nov;100:103-108. doi: 10.1016/j.jpba.2014.07.027. Epub 2014 Aug 1.
7
Oral matrix tablet formulations for concomitant controlled release of anti-tubercular drugs: design and in vitro evaluations.用于抗结核药物联合控释的口腔基质片制剂:设计与体外评价
Int J Pharm. 2008 Oct 1;362(1-2):118-25. doi: 10.1016/j.ijpharm.2008.06.019. Epub 2008 Jul 3.
8
Formulation of Tyloxapol niosomes for encapsulation, stabilization and dissolution of anti-tubercular drugs.妥尔油脂肪酸聚氧乙烯醚(Tyloxapol)非离子脂质体的配方,用于包裹、稳定和溶解抗结核药物。
Colloids Surf B Biointerfaces. 2013 Jan 1;101:434-41. doi: 10.1016/j.colsurfb.2012.07.006. Epub 2012 Jul 17.
9
Design and evaluation of enteric-coated tablets for rifampicin and isoniazid combinations.利福平与异烟肼复方肠溶片的设计与评价。
Pharm Dev Technol. 2013 Mar-Apr;18(2):401-6. doi: 10.3109/10837450.2012.659254. Epub 2012 Feb 18.
10
Formulation, optimization, and characterization of rifampicin-loaded solid lipid nanoparticles for the treatment of tuberculosis.利福平载固体脂质纳米粒的制备、优化及表征及其在结核病治疗中的应用。
Drug Dev Ind Pharm. 2018 Dec;44(12):1975-1989. doi: 10.1080/03639045.2018.1506472. Epub 2018 Aug 31.

引用本文的文献

1
Biodistribution of Tc-99m Labeled Isoniazid Solid Lipid Nanoparticles in Wistar Rats.Tc-99m标记异烟肼固体脂质纳米粒在Wistar大鼠体内的生物分布
Iran J Pharm Res. 2018 Fall;17(4):1209-1216.